205 related articles for article (PubMed ID: 28841000)
1. First Case of Echinocandin-Resistant Candida albicans in Korea.
Park MS; Park JE; Song DJ; Huh HJ; Park S; Kang CI; Shin JH; Lee NY
Ann Lab Med; 2017 Nov; 37(6):556-558. PubMed ID: 28841000
[No Abstract] [Full Text] [Related]
2. Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the
Cheung YY; Hui M
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827418
[TBL] [Abstract][Full Text] [Related]
3. Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.
Wiederhold NP; Grabinski JL; Garcia-Effron G; Perlin DS; Lee SA
Antimicrob Agents Chemother; 2008 Nov; 52(11):4145-8. PubMed ID: 18794385
[TBL] [Abstract][Full Text] [Related]
4. Resistance to echinocandins comes at a cost: the impact of FKS1 hotspot mutations on Candida albicans fitness and virulence.
Ben-Ami R; Kontoyiannis DP
Virulence; 2012; 3(1):95-7. PubMed ID: 22286697
[TBL] [Abstract][Full Text] [Related]
5. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.
Lackner M; Tscherner M; Schaller M; Kuchler K; Mair C; Sartori B; Istel F; Arendrup MC; Lass-Flörl C
Antimicrob Agents Chemother; 2014 Jul; 58(7):3626-35. PubMed ID: 24733467
[TBL] [Abstract][Full Text] [Related]
6. Clinical perspectives on echinocandin resistance among Candida species.
Shields RK; Nguyen MH; Clancy CJ
Curr Opin Infect Dis; 2015 Dec; 28(6):514-22. PubMed ID: 26524326
[TBL] [Abstract][Full Text] [Related]
7. The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicans.
Wiederhold NP; Najvar LK; Fothergill AW; Bocanegra R; Olivo M; McCarthy DI; Kirkpatrick WR; Fukuda Y; Mitsuyama J; Patterson TF
Antimicrob Agents Chemother; 2015 Feb; 59(2):1341-3. PubMed ID: 25451054
[TBL] [Abstract][Full Text] [Related]
8. Acquired echinocandin resistance in a Candida krusei blood isolate confirmed by mutations in the fks1 gene.
Prigitano A; Esposito MC; Cogliati M; Pitzurra L; Santamaria C; Tortorano AM
New Microbiol; 2014 Apr; 37(2):237-40. PubMed ID: 24858652
[TBL] [Abstract][Full Text] [Related]
9.
Jiménez-Ortigosa C; Perez WB; Angulo D; Borroto-Esoda K; Perlin DS
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630180
[TBL] [Abstract][Full Text] [Related]
10. Abdominal candidiasis is a hidden reservoir of echinocandin resistance.
Shields RK; Nguyen MH; Press EG; Clancy CJ
Antimicrob Agents Chemother; 2014 Dec; 58(12):7601-5. PubMed ID: 25288081
[TBL] [Abstract][Full Text] [Related]
11. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
[TBL] [Abstract][Full Text] [Related]
12. Echinocandin failure case due to a previously unreported FKS1 mutation in Candida krusei.
Jensen RH; Justesen US; Rewes A; Perlin DS; Arendrup MC
Antimicrob Agents Chemother; 2014 Jun; 58(6):3550-2. PubMed ID: 24687511
[TBL] [Abstract][Full Text] [Related]
13. Emergence of Candida tropicalis resistant to caspofungin.
Pasquale T; Tomada JR; Ghannoun M; Dipersio J; Bonilla H
J Antimicrob Chemother; 2008 Jan; 61(1):219. PubMed ID: 18024953
[No Abstract] [Full Text] [Related]
14. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
Zhang L; Yang HF; Liu YY; Xu XH; Ye Y; Li JB
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
[TBL] [Abstract][Full Text] [Related]
15. Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin.
Imtiaz T; Lee KK; Munro CA; MacCallum DM; Shankland GS; Johnson EM; MacGregor MS; Bal AM
J Med Microbiol; 2012 Sep; 61(Pt 9):1330-1334. PubMed ID: 22653922
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
Kritikos A; Neofytos D; Khanna N; Schreiber PW; Boggian K; Bille J; Schrenzel J; Mühlethaler K; Zbinden R; Bruderer T; Goldenberger D; Pfyffer G; Conen A; Van Delden C; Zimmerli S; Sanglard D; Bachmann D; Marchetti O; Lamoth F;
Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
[TBL] [Abstract][Full Text] [Related]
17. Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis.
Laverdière M; Lalonde RG; Baril JG; Sheppard DC; Park S; Perlin DS
J Antimicrob Chemother; 2006 Apr; 57(4):705-8. PubMed ID: 16464893
[TBL] [Abstract][Full Text] [Related]
18.
Suwunnakorn S; Wakabayashi H; Kordalewska M; Perlin DS; Rustchenko E
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358288
[No Abstract] [Full Text] [Related]
19. Evaluation of the "Dip Effect" Phenomenon in Antifungal Susceptibility Testing of Candida spp. against Echinocandins by Use of Gradient Concentration Strips.
Siopi M; Tsala M; Siafakas N; Zerva L; Meletiadis J
J Clin Microbiol; 2015 Nov; 53(11):3654-9. PubMed ID: 26338855
[TBL] [Abstract][Full Text] [Related]
20. Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis.
Jensen RH; Johansen HK; Arendrup MC
Antimicrob Agents Chemother; 2013 Jan; 57(1):614-7. PubMed ID: 23089761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
